PTHLH and renal cell carcinoma: Upon arrival in bone, metastatic breast, lung or RCC cancer cells secrete PTHrP which acts on osteoblasts to trigger an increased release of RANKL and reduced expression of the RANKL-antagonist osteoprotegerin (OPG).